6

NuPathe Inc. Completes $30 Million Series B Financing (Business Wire)

http://us.rd.yahoo.com –

CONSHOHOCKEN, Pa.----NuPathe Inc., a privately held specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, announced that the company has raised $30 million in a recently completed Series B equity financing.

Read »
6 weeks 2 days ago – Made popular 6 weeks 2 days ago
Category: Venture Capital   Tags:

Similar stories

NuPathe Raises $30 Million 6 weeks 2 days ago
Collegium Pharmaceutical Announces Completion of Series D Financing (Business Wire) 7 weeks 5 days ago
IRX Therapeutics Completes $25 Million Series A Preferred Stock Offering (Business Wire) 13 weeks 5 days ago
Sierra Neuropharmaceuticals Completes $21.5-Million Series A Funding Round (PR Newswire) 5 weeks 3 days ago

Navigation

User login

If you don't see your content here, learn more about importing to on this page.
Private Equity News and Advice